Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HPGDS | O60760 | 8/20 | 0.35 |
| ▸ | ABL1 | P00519 | 5/20 | 0.34 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.32 |
| ▸ | LIPC | P11150 | 1/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ALPL | P05186 | 1/20 | 0.31 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3617630 | 0.88 | HPGDS (0.33) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL3618996 | 0.88 | HPGDS (0.39) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL3616459 | 0.84 | ALDH1A1 (0.37) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL3605351 | 0.83 | MAPT (0.37) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL3615835 | 0.83 | ALDH1A1 (0.36) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL3609547 | 0.78 | ALDH1A1 (0.39) | ALDH1A1F2GLAHPGDABL1 | |
| SCHEMBL6171280 | 0.73 | ALDH1A1 (0.33) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL3617930 | 0.73 | ALDH1A1 (0.34) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL3621354 | 0.73 | ALDH1A1 (0.34) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL534860 | 0.73 | SCN9A (0.37) | ALDH1A1F2GLAHPGDHPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100113513-A1 | QUINOLINE DERIVATIVES AS FUNGICIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| EP-2139324-A1 | QUINOLINE DERIVATIVES AS FUNGICIDES | Syngeta Participations AG (CH) | 2010-01-06 | — | — | EP | disclosed |
| WO-2008110355-A1 | QUINOLINE DERIVATIVES AS FUNGICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2008-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113513-A1 | QUINOLINE DERIVATIVES AS FUNGICIDES | CYP1A1, CYP4X1, CYP3A7 | ALDH1A1 350/4885F2 4394/4885GLA 2537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.